Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Diabetes

Free Subscription Articles published in Am J Manag Care Retrieve available abstracts of 31 articles: HTML format

Single Articles

April 2026
1. GOOD CB, Beren IA, Rosenberg EM, Peasah SK, et al
   Medication use for patients with obesity: trends and characteristics for US employees.
   Am J Manag Care. 2026;32:238-244.
   PubMed     Abstract available
   
   
   March 2026
2. GOETSCHIUS L, Barefoot D, Han F, Sun R, et al
   Predicting severe diabetes complications using administrative claims data in Maryland.
   Am J Manag Care. 2026;32:e66-e70.
   PubMed     Abstract available
   
   
   December 2025
3. SHENOY DA, Cummins L, Kaplan S, Zullig LL, et al
   Interventions addressing cost-related medication nonadherence in diabetes: a scoping review.
   Am J Manag Care. 2025;31.
   PubMed     Abstract available
   
   
   
4. PANGRACE M, Albright J, Basta S, Bratcher T, et al
   Exploratory study of selected stakeholder insights into continuous glucose monitoring in T2D with risk-sharing agreements.
   Am J Manag Care. 2025;31.
   PubMed     Abstract available
   
   
   
5. SHOAIB N, Azhar N, Shoaib M
   GLP-1 receptor agonists: trend, necessity, or blessing?
   Am J Manag Care. 2025;31.
   PubMed     Abstract available
   
   
   
6. PATEL BV, Wang SM, Messer LH, Pinsker JE, et al
   HEDIS glycemic goal achieved using control-IQ Technology.
   Am J Manag Care. 2025;31:e357-e363.
   PubMed     Abstract available
   
   
   November 2025
7. BORRELLI EP, Saad P, Barnes NE, Beer I, et al
   Relationship between medication adherence and other Medicare star rating measures.
   Am J Manag Care. 2025;31:688-692.
   PubMed     Abstract available
   
   
   October 2025
8. TURK MT, Ritchie ND, Norton B, Gallucci A, et al
   Opportunities and obstacles associated with the Medicare Diabetes Prevention Program.
   Am J Manag Care. 2025;31:578-582.
   PubMed     Abstract available
   
   
   September 2025
9. KAUR M, Ives B, Mijanovich T, Singh P, et al
   Workforce innovation reduces Medicaid costs in chronic care.
   Am J Manag Care. 2025;31.
   PubMed     Abstract available
   
   
   
10. LIU G, Jarema M, Mo M, Stievater T, et al
    Navigating compounded semaglutide: what health care providers need to know.
    Am J Manag Care. 2025;31:480-484.
    PubMed     Abstract available
    
    
    August 2025
11. UKHANOVA M, Wozny JS, Truong CN, Ghosh L, et al
    Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.
    Am J Manag Care. 2025;31:e228-e234.
    PubMed     Abstract available
    
    
    
12. TREMBLAY ES, Argetsinger S, Zhang F, Ross-Degnan D, et al
    Trends in insulin out-of-pocket costs and use disparities, 2008-2021.
    Am J Manag Care. 2025;31:408-412.
    PubMed     Abstract available
    
    
    April 2025
13. MARRERO DG, Parkin CG, Aleppo G, Hirsch IB, et al
    The role of advanced technologies in improving diabetes outcomes.
    Am J Manag Care. 2025;31:e102-e112.
    PubMed     Abstract available
    
    
    
14. KOMMAREDDI M, Wherry K
    Cost-effectiveness of the MiniMed 780G system for type 1 diabetes.
    Am J Manag Care. 2025;31:e79-e86.
    PubMed     Abstract available
    
    
    
15. NEMLEKAR PM, Hannah KL, Green CR, Grace T, et al
    Combined effect of continuous glucose monitoring and semaglutide: analysis of administrative claims.
    Am J Manag Care. 2025;31:183-188.
    PubMed     Abstract available
    
    
    March 2025
16. ABRAHAM JM, Ambroz T, Chacon M, Kidney RSM, et al
    Real-world digitally based diabetes management program implementation by a large employer.
    Am J Manag Care. 2025;31:e62-e68.
    PubMed     Abstract available
    
    
    January 2025
17. VILLAVERDE Z, Hinman RH 2nd, Grimes RM
    Physiologic insulin resensitization lowers cost in patients with diabetes and kidney disease.
    Am J Manag Care. 2025;31:e11-e14.
    PubMed     Abstract available
    
    
    
18. ERNST K, Thompson AN, Bensami A, Choe HM, et al
    Collaboration to transition members to preferred formulary dipeptidyl-peptidase-4 inhibitor.
    Am J Manag Care. 2025;31:20-24.
    PubMed     Abstract available
    
    
    December 2024
19. NEELAND IJ, Rajagopalan S
    A team-based approach to type 2 diabetes and cardiovascular care.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    
20. HANDELSMAN Y
    Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic disease.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    
21. FERDINAND KC
    An overview of cardiovascular-kidney-metabolic syndrome.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    September 2024
22. BETTS KA, Oberprieler NG, Wu A, James G, et al
    Antihyperglycemic treatment patterns for chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2024;30:405-412.
    PubMed     Abstract available
    
    
    August 2024
23. HUANG HC, Touchette DR, Tadrous M, Schumock GT, et al
    Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study.
    Am J Manag Care. 2024;30:e226-e232.
    PubMed     Abstract available
    
    
    May 2024
24. POONAWALLA IB, Chung L, Shetler S, Pearce H, et al
    Medication adherence star ratings measures, health care resource utilization, and cost.
    Am J Manag Care. 2024;30:210-217.
    PubMed     Abstract available
    
    
    
25. NOBLE M, Chen F, Linke S, Dall TM, et al
    Modeling the economic value of cardiometabolic virtual-first care programs.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    April 2024
26. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
    Medication persistence and its impact on type 2 diabetes.
    Am J Manag Care. 2024;30:e124-e134.
    PubMed     Abstract available
    
    
    
27. KUMAR A, Dowd-Green C, Green R, Stewart R, et al
    Institutional practices for charitable medication access for uninsured patients.
    Am J Manag Care. 2024;30:e135-e139.
    PubMed     Abstract available
    
    
    March 2024
28. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
    Improving glycemic control in diabetes through virtual interdisciplinary rounds.
    Am J Manag Care. 2024;30:e78-e84.
    PubMed     Abstract available
    
    
    
29. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
    Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
    Am J Manag Care. 2024;30:107-108.
    PubMed     Abstract available
    
    
    
30. LAMONICA LC, Ren J, Jain N, Goldberg ES, et al
    At-home hemoglobin A1c testing during COVID-19 improved glycemic control.
    Am J Manag Care. 2024;30:e73-e77.
    PubMed     Abstract available
    
    
    
31. LO JC, Chandra M, Yang W, Thompson N, et al
    Challenges of fracture risk assessment in Asian and Black women.
    Am J Manag Care. 2024;30:140-144.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum